RSC Publishing


Publishing

 

Cover image for Chemical Communications, select for current issue

Chemical Communications

Urgent high quality communications from across the chemical sciences.



Subscribers

  • HTML article

Free access



Feature Article

Chem. Commun., 2007, 4978 - 4991, DOI: 10.1039/b707257k

Carboranyl thymidine analogues for neutron capture therapy

Werner Tjarks, Rohit Tiwari, Youngjoo Byun, Sureshbabu Narayanasamy and Rolf. F. Barth

Neutron capture therapy (NCT) is a binary radio-chemotherapeutic modality for the treatment of cancer. A major focus of NCT-related research is the development of novel tumor-selective agents that serve as the chemical component in NCT. Thymidine analogues substituted with a boron-containing carborane cluster at the N3 position, designated 3CTAs (3-carboranyl thymidine analogues), constitute one class of these new improved NCT agents. Their chemical, structural and biological properties are discussed in this Feature Article.

Graphical abstract image for this article (ID: b707257k)